GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.

Date

2019

Author

Ertan-Ahmed, Senem
Kiehl, Michael G.
Radinoff, Atanas
Graklanov, Vasko
Tzvetkov, Nikolay
Mihaescu, Rodica
Sung, Young Chul

Metadata

Show full item record

Abstract

…

Source

Journal of Clinical Oncology

Volume

37

Issue

15

URI

https://hdl.handle.net/20.500.12712/10834

Collections